79405513 - NORDICENDOTROPHIN

Information

• Trademark
• 79405513

• Source

• Serial Number

  79405513

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  August 23, 2024
  10 months ago

• Transaction Date

  May 05, 2025
  a month ago

• Status Date

  April 12, 2025
  2 months ago

• Status Code

  641

• Current Location

  TMEG LAW OFFICE 108

  Employee Name

  HACK, ANDREA

• Law Office Assigned Location Code

  L80

• Owners

  • Nordic Bioscience A/S

Case File Statements

• GS0051: Diagnostic biomarker reagents for medical and clinical purposes; biomarkers for use individually or in combination to detect tissue formation, tissue remodeling, or tissue destruction; biomarker assays to identify disease activity; biomarker assays to quantify disease activity; biomarker assays to analyse disease activity; diagnostic kits comprised of medical diagnostic reagents and assays for use in disease detection, disease analysis and quantifying disease activity; medical diagnostic agents; medical diagnostic reagents; clinical diagnostic agents; clinical diagnostic reagents; diagnostic preparations, substances and materials; medical diagnostic test strips; diagnostic preparations for medical purposes; diagnostic agents for medical use.
• PM0001: NORDIC ENDOTROPHIN
• GS0421: Design and development of blood-based biomarker assays to identify, quantify and analyse disease activity; design and development of diagnostic biomarker reagents for medical, pharmaceutical, and scientific purposes; design and development of biochemical, pharmaceutical, and medical assays; design and development of biomarkers for use individually or in combination to detect tissue formation, tissue remodeling, or tissue destruction; scientific and pharmaceutical research in the field of biomarkers and biomarker discovery; identification of predictive and prognostic biomarkers for clinical trials; identifing patients for clinical trials most likely to respond to a given treatment using biomarkers; laboratory services relating to clinical trials; clinical trials; analysis of pharmacodynamic data; analysis of data relating to biomarkers; development of diagnostic preparations, equipment and tests; clinical testing services; diagnostic testing services; testing services relating to the detection and measurement of biomarkers; testing samples for the presence of biomarkers; laboratory services; medical laboratory services; research laboratory services; medical, pre-clinical, clinical, biological, biotechnological and pharmaceutical research, experimentation, development, and analysis; advice, information and assistance relating to the foregoing.

Case File Event Statements

• 10/3/2024 - 8 months ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR

• 10/8/2024 - 8 months ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 2/27/2025 - 4 months ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 10/8/2024 - 8 months ago

  3 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 3/6/2025 - 3 months ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 3/7/2025 - 3 months ago

  6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 4/12/2025 - 2 months ago

  8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 4/12/2025 - 2 months ago

  7 - REFUSAL PROCESSED BY MPU Type: RFRR

• 5/4/2025 - a month ago

  9 - REFUSAL PROCESSED BY IB Type: RFNT